• Chlorpromazine HCl (SKU B1480): Reliable Solutions for Cell

  2026-07-31

  This article addresses common laboratory challenges in cell viability, endocytosis, and neuropharmacology assays, providing scenario-driven guidance for using Chlorpromazine HCl (SKU B1480). Drawing on peer-reviewed evidence and real-world lab experience, it demonstrates how Chlorpromazine HCl ensures reproducibility and mechanistic rigor for advanced experimental workflows.

• Strategic Deployment of Dual Luciferase Reporter Gene System

  2026-07-31

  Explore the mechanistic sophistication and translational impact of dual luciferase reporter gene systems, with strategic guidance for leveraging APExBIO’s Dual Luciferase Assay System in high-throughput studies of gene expression regulation. Drawing on recent advances in autophagy and oncogenic pathways, this article connects experimental best practices to clinical aspirations, offering actionable insights for translational researchers seeking to accelerate discovery.

• Angiotensin 1/2 (2-7): A Translational Lever in Vascular Bio

  2026-07-30

  This thought-leadership article delves into the mechanistic and translational significance of Angiotensin 1/2 (2-7), a vasoconstrictor peptide fragment at the intersection of cardiovascular and infectious disease research. Drawing on recent mechanistic findings and advanced protocol guidance, it provides strategic recommendations for translational researchers aiming to unlock new therapeutic frontiers.

• Chlorpromazine HCl: Dopamine Receptor Antagonist in Applied

  2026-07-30

  Chlorpromazine HCl stands out as a versatile dopamine receptor antagonist, powering rigorous neuropharmacology, host-pathogen, and cell biology workflows. Explore protocol enhancements, troubleshooting strategies, and a novel host-directed application that extend far beyond classical antipsychotic paradigms.

• 5-Azacytidine (A1907): Reliable Epigenetic Modulation in Can

  2026-07-29

  This article addresses key laboratory challenges in cell-based cancer research, demonstrating how 5-Azacytidine (SKU A1907) empowers reproducible, quantitative workflows. Through scenario-driven Q&A, we highlight practical solutions for DNA demethylation, apoptosis induction, and vendor selection, ensuring that biomedical scientists achieve robust results with APExBIO’s 5-Azacytidine.

• Stiripentol: LDH Inhibition, Lactate Signaling, and Immune M

  2026-07-29

  Explore how Stiripentol, a novel LDH inhibitor, enables advanced research into lactate metabolism, astrocyte-neuron signaling, and immune regulation. This in-depth article uncovers new scientific perspectives for epilepsy and tumor microenvironment studies.

• Gut-Brain Cholinergic Signaling in Microbiota-Mediated Seizu

  2026-07-28

  Jia et al. identify a gut-vagus-brain cholinergic pathway through which Bacteroides fragilis suppresses seizures in pediatric refractory epilepsy. Their translational findings provide mechanistic insight into microbiota-driven acetylcholine neurotransmitter signaling and open new avenues for targeted epilepsy interventions.

• Hypoxia-Activated Photomolecular Glues Advance Cancer Therap

  2026-07-28

  This study introduces a hypoxia-responsive photomolecular glue, BNNC, which synergistically targets Cyclin K degradation and delivers phototherapy in breast cancer models. The innovation offers improved tumor specificity and therapeutic efficacy over existing molecular glue strategies, with important implications for combinatorial cancer treatments.

• Pepstatin A: Precision Aspartic Protease Inhibition in Cell

  2026-07-27

  Explore Pepstatin A's role as a gold-standard aspartic protease inhibitor in advanced cellular research. This article uniquely bridges molecular mechanisms with assay design, offering in-depth guidance for experimental optimization.

• Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor In

  2026-07-27

  Wang et al. dissected the cellular entry mechanism of type III grass carp reovirus (GCRV104), revealing a strict dependence on clathrin-mediated endocytosis and endosomal acidification. Their findings clarify the molecular basis of GCRV104 infection, informing potential antiviral strategies and enhancing our understanding of viral entry in aquatic pathogens.

• Octenidine Dihydrochloride: Workflows, Innovations, and Trou

  2026-07-26

  Octenidine dihydrochloride stands out as a research-grade chemical antiseptic with robust membrane-disruptive action and superior solubility, empowering reproducible antimicrobial assays. This article dissects practical protocols, experimental enhancements, and troubleshooting strategies to maximize reliability and address common pitfalls in antiseptic compound research.

• BMS 599626 Dihydrochloride: EGFR/ErbB2 Inhibitor in Cancer W

  2026-07-25

  BMS 599626 dihydrochloride delivers selective, potent EGFR and ErbB2 inhibition, enabling precise dissection of oncogenic signaling in breast and lung cancer models. Its robust performance in both in vitro and in vivo contexts, paired with actionable workflow enhancements, positions it as a cornerstone for next-generation cancer and senescence research.

• Chlorpromazine HCl in Host-Pathogen Cell Entry: Mechanistic

  2026-07-24

  Explore how Chlorpromazine HCl, a potent dopamine receptor antagonist, enables advanced investigation of cellular entry mechanisms in host-pathogen models. This article uniquely bridges neuropharmacology and infection biology, offering protocol guidance and novel insights for psychotic disorder and endocytosis research.

• DiscoveryProbe Protease Inhibitor Library: Applied Workflows

  2026-07-24

  The DiscoveryProbe Protease Inhibitor Library delivers unmatched diversity and automation-ready convenience for high throughput screening of protease inhibition in cancer, apoptosis, and infectious disease research. This article offers granular workflow guidance, highlights strategic troubleshooting, and translates cutting-edge findings—like the PSMD14–CARM1 axis—into actionable assay decisions.

• Chlorpromazine HCl: Dopamine Receptor Antagonist in Research

  2026-07-23

  Chlorpromazine HCl is a validated dopamine receptor antagonist widely used in neuropharmacology and host-directed antibacterial research. Its mechanism involves potent, competitive inhibition of central dopamine receptors and modulation of neuroimmune pathways. APExBIO’s reagent (SKU B1480) remains a gold-standard tool for dissecting synaptic, endocytic, and macrophage functions.

16309 records 1/1088 page Next 12345 下5页 Last page